Clinical Trial Update: Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomarker of Crohn's Disease Activity [NA]

View source ↗

Summary

The update discusses urinary PGE-M as a novel biomarker for Crohn's disease activity, based on a completed trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Crohn's Disease | NA | Status: COMPLETED